Difference between revisions of "NCCN guidelines"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
Line 38: Line 38:
 
*'''2007:''' Crawford et al. [https://doi.org/10.6004/Jnccn.2007.0019 Myeloid growth factors. Clinical practice guidelines in oncology.] [https://pubmed.ncbi.nlm.nih.gov/17335688/ PubMed]
 
*'''2007:''' Crawford et al. [https://doi.org/10.6004/Jnccn.2007.0019 Myeloid growth factors. Clinical practice guidelines in oncology.] [https://pubmed.ncbi.nlm.nih.gov/17335688/ PubMed]
 
*'''2005:''' Crawford et al. [https://doi.org/10.6004/Jnccn.2005.0030 Myeloid growth factors clinical practice guidelines in oncology.] [https://pubmed.ncbi.nlm.nih.gov/16038645/ PubMed]
 
*'''2005:''' Crawford et al. [https://doi.org/10.6004/Jnccn.2005.0030 Myeloid growth factors clinical practice guidelines in oncology.] [https://pubmed.ncbi.nlm.nih.gov/16038645/ PubMed]
 +
 +
=Palliative Care=
 +
*'''2009:''' Levy et al. [https://doi.org/10.6004/Jnccn.2009.0031 NCCN clinical practice guidelines in oncology: palliative care.] [https://pubmed.ncbi.nlm.nih.gov/19406043/ PubMed]
  
 
=Survivorship=
 
=Survivorship=

Revision as of 20:38, 2 December 2023

This page will be a gathering place for the National Comprehensive Cancer Network (NCCN) guidelines that do not clearly fit under a disease-specific page.

Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any article published 5+ years ago to be for historical purposes, only.

Bone Health

Cancer Screening

Cancer Related Infections

Cancer Risk Reduction

Middle East and North Africa

Myeloid Growth Factor

Palliative Care

Survivorship

Fatigue